A Guest Post: The Long Way Back to Believing in Research

By Ryan Fightmaster, Editor of Diabetes Daily Grind. Click here to learn more about Ryan. 

GREER-INEZ-8330-366x550I came to take research for granted. Why? Well, it’s complicated. When first diagnosed, you jump in every clinical trial around, usually at the first mention by your doctor. I joined three as a kid. We’re beyond gung ho at this point, we’re pushing the needle toward a cure. Subtly, the years go by. You look around and think, Man, this technology development is pretty awesome, but I’m still on insulin. To hold the belief that one day you’ll eat with no conscious weighing of risks and benefits (I’m not advocating this for anyone, just getting at a point) while also weighing all the risks and benefits of every choice in your life every day for most of your life, is tough.

Eventually, some of us end up slandering the poor mouse who lost its beta cells (unwillingly I might add) to test a novel therapy that ends up curing said mouse of diabetes. Then, we watch said therapy disappear somewhere down the never-ending FDA approval process rabbit hole, hoping and praying that one day (in our lifetime, or our kids’) it will magically reappear at an affordable price.

Before the dawn of DiabetesDailyGrind, this was my stance: stoic in the belief that I will be taking insulin for the rest of my life. But slowly, that attitude has dissolved and morphed into a knowing, a firm stance that one day everyone will be freed from the daily grind of diabetes – not just those in the artificial pancreas trials, or with the funds to eventually own an artificial pancreas. Why the change of heart you may be asking? Because there are so many people working to make it happen.

In January, I attended the JDRF Type 1 Nation Summit in Oklahoma City, where I saw someone in the artificial pancreas trial speak. It was working. It was actually administering insulin for her, with the help of a continuous glucose monitor. There was something about seeing her live, in person, that tangible experience, that made it click: I have to get involved in research too. Let’s hit the tipping point.

Right about here I found TrialReach. Their website, TrialReach.com, is basically the Tinder of clinical trials (without the swiping, weird spam bots, ex-girlfriends, and guilt). With the worst possible analogy out of the way, we can get to why it works. Much of the time, clinical trials are hard to find and once you do find something, you’re left wondering if a better trial is out there (now it’s your turn to make that last sentence into a Tinder analogy).

At TrialReach.com, you start with your zip code, answer a few demographic questions and a few questions specific to your health, and you’re set up with a list of trial choices, near you, that are likely a match for you. In just 41 seconds, I was linked up with 3 possible trials in Oklahoma City where I fit their participant criteria. One trial testing sotagliflozin’s efficacy in type 1 diabetes patients looks really intriguing, if you’re into the whole kidney excretion of glucose thing. They also provide an email sign-up option, where they send the next available clinical trial your way.

We are close. Ten years ago I would have said that close meant a cure 10 years out. Now, I’m removing expectations – just looking to do my part to push that “close” a little farther. It’s time to get involved.

TrialReach is a partner of DiabetesDailyGrind.com. We believe a little transparency is good for us all. Reprinted with permission.


For Clinical Trials Awareness Week: Clinical Trials 101

It’s Clinical Trials Awareness Week! This year’s focus is on enrollment and participation, which are absolutely crucial to ensuring that medical research advances. Did you know 85% of trials are delayed or cancelled because researchers can’t find enough patients to take part? These delays make it take longer and cost more than it should to develop new drugs and treatments.

Read on to learn more about trials and how you can get involved by visiting www.trialreach.com.


What is a clinical trial?

Clinical trials help researchers determine if investigational drugs or treatments are safe and effective. All investigational medications and devices must undergo clinical trials before they are made available to patients.

Who can participate in a clinical trial?

All clinical trials have strict guidelines about who can participate. “Inclusion criteria” are the characteristics that a person must have to participate in a clinical trial. “Exclusion criteria” are the characteristics that may prevent someone from participating. It is important for researchers to carefully follow these guidelines so they are able to answer the questions they are studying and so they can keep participants safe. 

Why should I participate in a clinical trial?

You will have access to new, investigational treatments that, if approved, will be available to the general public. You will also receive study-related medical care and attention from clinical trial staff at research facilities. And, importantly, by participating in a trial you can help researchers find better treatments – and maybe cures.

What should I consider before participating in a trial?

You should know as much as possible about the clinical trial and feel comfortable asking the members of the health care team questions. The following questions might be helpful to discuss with the health care team.

  • What is the purpose of the study?
  • Who is going to be in the study?
  • Why do researchers believe the new treatment being tested may be effective? Has it been tested before?
  • What kinds of tests and treatments are involved?
  • How do the possible risks, side effects, and benefits in the study compare with my current treatment?
  • How might this trial affect my daily life?
  • How long will the trial last?
  • Will hospitalization be required?
  • Who will pay for the treatment?
  • Will I be reimbursed for other expenses?
  • What type of long-term follow up care is part of this study?
  • How will I know that the treatment is working? Will results of the trials be provided to me?
  • Who will be in charge of my care?

What are the benefits and risks of clinical trials?

Before you can participate in any clinical trial, you will be asked to review and sign an informed consent form (ICF), which will explain the potential benefits, risks, and side effects that you may experience while taking part in the clinical trial. The investigational treatment may or may not help to make your condition better. While you may have a positive trial experience, you may also experience unpleasant or serious side effects. It’s important to discuss the benefits and risks with your doctor before making any decisions.

Screen Shot 2015-12-01 at 5.20.38 PM

How will my safety be protected?

The ethical and legal codes that govern medical practice also apply to clinical trials. In addition, clinical research is federally regulated with built-in safeguards to protect participants. Every trial has a carefully controlled protocol, which is a detailed plan the researchers will follow. As a clinical trial progresses, researchers provide regular reports to review boards. These review boards make sure the researchers are following the study plan and all ethical and legal codes. Throughout the trial, the researchers will also report what they learn at scientific meetings, to medical journals, and to various government agencies. Participant names will remain confidential and will not be mentioned in these reports.

What kind of preparation should I do for the meeting with the research coordinator or doctor?

  • Plan ahead and write down your questions.
  • Ask a friend or relative to come along for support and to hear the responses to the questions.
  • Record the discussion to replay later.

Can I leave a clinical trial after it has begun?

Yes. You can leave a clinical trial at any time. When withdrawing from the trial, you should let the research team know and share the reasons for leaving the study.

Can I continue to work with my doctor during a clinical trial?

Yes. Most clinical trials provide short-term treatments related to a designated illness or condition, but do not provide extended or complete primary health care. In addition, by having the doctor work with the research team, the participant can ensure that other treatments will not conflict with the protocol.

Where can I find a clinical trial that’s right for me?

You can visit www.trialreach.com to be matched to clinical trials in your area. Just enter your location and answer a few questions about your health and a list of trials that may be right for you will appear. You can then contact the trial coordinators through the site to get started.


Content courtesy of our partner, CISCRP.

Join Us for a Twitter Chat on Technology in Diabetes

We’re excited that tomorrow at 3PM ET, we’ll be taking part in a Twitter chat hosted by our friends at Diabetes News. We’ll be diving into issues around innovation in diabetes management, with a specific focus on technology and the role of community in that technology. We’ll be joined by two great companies in the space who we’re sure will have some interesting thoughts to share on the topic. Ahead of Thursday’s chat, we’d like to share a bit of background on these companies: One Drop and Lyfebulb.

One Drop is a diabetes management platform that allows people to track their daily activities and see the relationship that food, insulin, and activity have with glucose levels. In addition, it features a sharing component that allows users to learn from each other. One Drop has plans to roll out a bluetooth-enabled glucose meter that connects to the app for some of the most seamless tracking we’ve seen! And, it will be included in Apple’s new CareKit. Here’s a quick video on One Drop:

Lyfebulb is an organization that aims to improve quality of life for people living with chronic disease, including diabetes. The company organizes in-person events and an online community for people affected by chronic disease to share their stories, connect, and inspire each other. The founder, Dr. Karin Hehenberger, has an inspiring story to share:

We hope to see you online tomorrow!


Patient Perspectives on Clinical Trials, via Twitter

downloadLast week, we were pleased to share some key insights from our friends at the Center for Information and Study on Clinical Research Participation (CISCRP). From January to March 2015, CISCRP surveyed about 12,000 people around the world, asking them to share their opinions on clinical trials. The results are fascinating – and reveal a great need for clinical trial education and awareness. Our tweets generated interesting conversation about important topics, highlighting barriers to clinical trial participation, ways in which researchers (and others) can better communicate about trials, and the role of social media in educating on and recruiting for clinical trials. In case you missed it, we’ve included a transcript below.

@TrialReach: 51% of those surveyed would prefer to learn about trials from their doctors, but only 23% do – definitely room for improvement. @CISCRP

@TrialReach: People place the most trust in gov’t sources of trial info but http://CT.gov  is difficult. Patient-centric info is key! @CISCRP

@TrialReach: The most important info when considering a trial are risks/benefits. But, there are others (via @CISCRP). Thoughts?Untitled

@TrialReach: Patients want to know if they’ll have access to a drug after a trial is over, according to @CISCRP.

@TrialReach: Well over half of patients rarely or never discuss research with their doctors, via @CISCRP. What can patients do about this?

@PALSFirst: More importantly, how can doctors discuss #clinicaltrials and other #research with patients #endals #nowhiteflags

@scottkjohnson: @TrialReach @KellyRawlings @ninjabetic lack of time in appts is a big challenge. But maybe expressing an interest (on both sides) may help.

@scottkjohnson: @TrialReach @KellyRawlings @ninjabetic I also feel like there’s just not much awareness of opportunities.

@TrialReach: Just 5% of patients learn about trials through social media or online communities. How can we do better? @CISCRP

@askmanny: @TrialReach @AmyDBMine @DMomBlog depending on the trial recruitment targets, social media (so many flavors of it) may or may not help.

@PhyllisKaplan: @askmanny @TrialReach @AmyDBMine @DMomBlog My question is, how much can one share about the trial they are involved with?

@PhyllisKaplan: @askmanny @TrialReach @AmyDBMine @DMomBlog I just completed a trial and didn’t share much as I wasn’t sure how much I *could* share on SM.

@PhyllisKaplan: @TrialReach For the one I completed, they didn’t want big blog posts, but anything that could be found on the trial site was fair game.

@AmyDBMine: @PhyllisKaplan Usually there’s an agreement to sign specifying what’s confidential, no? @TrialReach @DMomBlog

@TrialReach: @PhyllisKaplan This is certainly a delicate area so this is definitely something you could talk to your site contact about!

@TrialReach: 36% of patients who are ineligible for one trial stop looking, via @CISCRP. Our Match product searches all trials so may help with this!

@TrialReach: 14% of patients live too far away to take part in a trial (via @CISCRP). Patient-centered trial design will meet patients where they are.

Screen Shot 2015-12-01 at 5.20.38 PM

@TrialReach: Can you believe 22% of patients are never told why they don’t qualify for a #clinicaltrial? (via @CISCRP) We can definitely do better.

@TrialReach: Why do people take part in trials? To help advance science, to help others, and to obtain better treatment (in that order) via @CISCRP.

@TrialReach: 3 main reasons for not taking part: not wanting to take a chance, fear of risk, and fear of being treated like a test subject. @CISCRP (1/1)

@TrialReach: What can we do to alleviate these concerns? (2/2)

@Groz_P: @TrialReach @CISCRP How about 1:Restrictive eligibility reqs 2:Limited access to trial sites 3: Byzantine pre-trial procedures…

@BBetJo: @TrialReach @CISCRP 1. Long washout periods. 2. Onerous requirements for participants. 3. Decreased QOL for no survival benefit.

@everydayupsdwns: @TrialReach @CISCRP Don’t forget No 4. Not knowing the trial is recruiting?

@TrialReach: @everydayupsdwns Huge issue! Awareness certainly needs to come first. Any ideas on how to improve this?

@everydayupsdwns: No idea! Things like this http://www.researchforthefuture.org/  or https://myglu.org/  but with wider reach?

@LuluChange14: @Groz_P @BBethJo @TrialReach @CISCRP 4. Trial drugs that are clones of approved drugs with far worse s/e. We want better drugs. Not more.

Screen Shot 2015-12-01 at 5.18.10 PM

@TrialReach: According to @CISCRP‘s survey, 89% of patients viewed clinical trials as safe. So why aren’t more patients taking part? Access is key. 

@TrialReach: A @CISCRP stat that warms our hearts: helping advance science and helping others remain the top perceived benefits from trial participation.

@TrialReach: 81% of people think clinical research is important to the discovery and development of new medicines. We encourage you to take part! @CISCRP

@TrialReach: 19% of those surveyed think they are not informed about clinical research. @CISCRP is working to address this education gap.

@TrialReach: 27% of patients report not being confident that they would find the right trial. What a shame – our new Match product addresses this @CISCRP

Thanks again to CISCRP for allowing us to share these results! This type of research is absolutely essential to drive these important conversations – and to inform the way we develop educational campaigns to drive clinical trial awareness.

This Valentine’s Day, Spare a Rose to Save a Child

If you follow TrialReach through our blog or social media channels, you know that we have been focusing on helping diabetes patients find and take part in clinical trials through our new free search tool, TrialReach Match™ . This is important because there can be no new treatments or cures for diabetes without people taking part in medical research.

Spare a Rose - Save a Child (PRNewsFoto/Partnering for Diabetes Change ()However, while we (im)patiently wait for better treatments to be developed, there are people living in other parts of the world who cannot afford to wait for these new drugs to be approved; people who live with uncontrolled diabetes because they don’t have access to even basic diabetes drugs such as insulin.

This week, our partner websites have been awash in a sea of digital red roses thanks to the Spare a Rose, Save a Child campaign. And we couldn’t help but take notice.

The premise of Spare a Rose, Save a Child is simple: Red roses are a staple of Valentine’s Day. So much so that an estimated $1.9 billion is spent on flowers each February 14th. Imagine what just a fraction of that amount could mean for a person who has trouble affording insulin. For the price of one rose ($5), you can provide a child living with diabetes the tools he or she needs to manage the disease for one month. For the price of a dozen roses ($60), you can provide those tools for a full year.

Thanks to last year’s campaign, the International Diabetes Federation (IDF) provided insulin, testing strips, and other essential services to more than 400 children around the globe. This year, IDF aims to double the number of children reached. If they are successful, the lives of nearly 1,000 young people will be made safer through access to basic diabetes treatments most of us take for granted.

At the heart of our work is the recognition that medical and technological advances bring peace of mind, hope, and health to people living around the globe. Campaigns like Spare a Rose, Save a Child remind us that behind every click on our website there is a person searching for potentially life-saving treatments. And while we work together to develop these new treatments, it is important to remember that a child with uncontrolled diabetes does not have the luxury of time.

So this Valentine’s Day we ask that you join us in buying a dozen digital roses. The two minutes you give today will buy a child in need another year to just be a kid.

Diabetes Trial Chat: What You Missed

Thanks to Healthline for this guest post! Click here for the original article. 

In January, Healthline hosted a Twitter chat (#DiabetesTrialChat) to talk about the challenges facing people with type 1 diabetes’ access to clinical trials aimed at finding new treatments, and potentially a cure. Taking part in the chat were:

  • Sarah Kerruish, chief strategy and growth officer at TrialReach. (Follow them@TrialReach)
  • Amy Tenderich, founder and editor-in-chief of DiabetesMine. (Follow them@DiabetesMine)
  • Dr. Sanjoy Dutta, assistant vice-president of translational development at JDRF. (Follow them @JDRF)

Read on to see what problems, and potential solutions, they and our wonderful community identified!

1. Over the past ten years, how has diabetes research changed the lives of patients?

sanjoyduttaDr. Sanjoy Dutta: “Increased awareness, decreased burden, reimbursement of continuous glucose monitoring (CGM), better outcomes using devices, and earlier diagnoses.”

Sarah Kerruish: “It’s changed everything. From islet transplantation to a potential artificial pancreas – huge progress has been made… I loved this article from the American Diabetes Association on all the progress made in the last 50 years.”

Amy Tenderich: “Research has given us CGM and soon artificial pancreas, andTrialNet to learn about causes of diabetes – amazing!”

From our community:

@everydayupsdwns: “Plenty of new gadgets and concoctions to smile about in T1D… Sensor augmented pump therapy springs to mind. Insulin analogues have helped many, but smart insulin looks amazing”

@ninjabetic1: “seeing that diabetes research is high up on the agenda gives me hope that I’ll have a happy & healthy life”

@JDRFQUEEN: “So much change. I first wore a Guardian Medtronic CGM in 2007. It was horrible, 100-200 pts off. Now AP worthy.”

2. What role do patients play in diabetes clinical research? What role should they play?

AT: “Patients should be MUCH more involved in conceptualizing studies! Check out the new VitalCrowd. See Anna McCollisterSlip launch slides on VitalCrowd crowdsourcing of diabetes clinical trials here.”sarahkerruish

SD: “Patients should also play an active role in providing perspective and feedback into trial design and outcomes.”

SK: “Yes! Influencing design is critical! They should play a HUGE role! Patients can best articulate their needs, so researchers should be listening carefully.”

From our community:

@AtiyaHasan05: “honesty. Being honest about what they are and are not doing according to research protocols.”

@ninjabetic1: “I think patients keep diabetes research on [its] toes (in a good way!) – The #wearenotwaiting projects are proof of that”

@JDRFQUEEN: “Clinicaltrials.gov [is a] good starting point for those looking to get involved in research!”

3. How can we better communicate the problem of a lack of clinical trial participation with patients?

AT: “Matching service for diabetes patients and researchers, like Living BioBank.”

SK: “Education! We’re doing our best to spread the word – 500,000 patients are needed for diabetes trials in the U.S., but 85 percent of trials are delayed or fail due to enrollment issues. That’s bad news for patients AND researchers.”

SD: “We need to be CANDID about each patient’s importance. They’re ambassadors of these trials and the greater good of all living with type 1 diabetes. Streamlined participation is key! Don’t bring the patient to trials; bring trials to the patient.”

SK: “Yes!”

From our community:

@ninjabetic1: “Ask HCPs to share this info better with appropriate patients. Research has never been mentioned to me in 13.5 years!”

@AtiyaHasan05: “explaining [the] complete process and their integral role in it. Most don’t fully understand how trials work.”

@everydayupsdwns: “Harness the power of social media! …Many studies suffer as [they are] geographically limited.”

4. What do you think are the most common barriers to clinical trial participation? How can they be addressed?

amytenderichSK: “Access! The info out there is for researchers, not patients – that’s why we created Match. We need to put patients at the center of research. What’s important to them? Dave deBronkart taught us this.”

AT: “People often e-mail us at Diabetes Mine asking how they or kids with type 1 diabetes can get involved in trials. Where is best to send them? The problem is that Clinicaltrials.gov is so VERY HARD to navigate.”

SD: “Direct and indirect participation is key, as well as open communication. A supportive ecosystem of caregivers & HCPs. There can be a mistrust of trials. Share the bigger picture and move from trial-centricity to patient-centricity.

AT: “Great idea! How would you suggest they accomplish that?”

SD: “Trials BASED on patient input. What would make their type 1 diabetes manageable? What are their preferences and limitations?”

SK: “It’s simple. Information and access. The vast majority of people don’t know about clinical trials. We’re trying to fix this.”

From our community:

@davidcragg: “Important factor for me is to see a commitment for the full methods and results to be reported regardless of outcome.”

@gwsuperfan: “More participant-friendly trials would increase participation. One wanted me to stay in a facility for [over two weeks]… Not a realistic thing for [people with diabetes] with jobs/school/lives.”

@everydayupsdwns: “Depends on trial design. Could be any number of things… I have offered participation several times, and signed up to be ‘found’ but only ever recruited by own clinic.”

@lawahlstorm: “Overcoming misconceptions about trial participation. The “guinea pig” fallacy.”

@ninjabetic1: “Time: how much time do I need to commit? Outcomes: will we seen results? Requirements: what do you need from me?”

5. How do we make clinical trials more focused on the needs of patients?

SD: “Reduce protocol complexity, and specific patient wants should be built-in when considering product development.”

SK: “Design with patients in mind! Researchers should think like patients and make sure it’s easy to take part in a trial. And don’t be afraid to ask! Patients know what’s best for patients, and researchers should take advantage of that.”

AT: “Also, we need something like Diabetes Research Connection to track what your trial is accomplishing.”

From our community:

@lwahlstrom: “Involve patients in every stage of trial design – beyond ‘test piloting.’ Community input is key!”

@ninjabetic1: “Run more tweet chats like this. Focus groups. Read blogs. Talk to us. Go past HCPs to reach the patients”

@JDRFQUEEN: “And not that one needs to be paid outrageous sums, but reimbursement for time and gas is a big incentive [for] participants.”

6. How can I find out which clinical trials to take part in?

SD: “A combination of personal research and the input of your health care provider.”

SK: “Check out our new tool, TrialReach Match – answer a few questions and our system will find trials for you!”

7. What resources do you recommend to learn more about clinical trials?

SD: “Clinicaltrials.gov, as well as JRDF.org”

SK: “Our friends CISCRP offer some great resources. And the diabetes online community is a great way to learn about personal experiences.”

8. What potential diabetes therapeutic advances are most exciting to you?

SK: “So many! I’m most intrigued by the artificial pancreas – imagine how many lives would be changed. I’m also interested in new research on turning stem cells into pancreatic beta cells – feels like major progress!”

AT: “Seriously. Patients and providers interviewed for [our] diabetes and marijuana article say STUDIES NEEDED. We’re excited about studies that will allow CGM to replace finger sticks.”

SD: “Automated artificial pancreas systems, beta cell replacement (encapsulation), kidney disease trials… Novel drugs for better glucose control, trials to preserve beta cell function.”

SK: “Two big, promising artificial pancreas trials coming up in 2016 via Harvard Research and UVA School of Medicine.”

From our community:

@OceanTragic: “OpenAPS for sure”

@NanoBanano24: “AP seems really close! Very excited about that.”

9. How close to a cure for diabetes do you think we are?

SK: “I don’t know how close, but just yesterday, this news gave me hope.”

From our community:

@delphinecraig: “I think we still have a long way to go to a cure.”

@davidcragg: “Not in my lifetime. A lot of media hype about cures around the corner are about securing funding for research”

@Mrs_Nichola_D: “10 years? Joking aside, I really don’t know. But not as quick as I’d like it to be.”

@NanoBanano24: “closer than ever! I’m 28, not sure it’s in my lifetime. A fabulous AP could be around in 10 years. Cautious optimist.”

@diabetesalish: “told for 38yrs that [diabetes] will be cured in 5 to 10 years. I need results not projection”

10. What’s the one thing you wish patients knew about clinical trials?

SD: “I wish patients knew how important they really are… Patients are players in and directors of a path to greater good for those living with type 1 diabetes.”

SK: “Most often, I field questions about finding trials – patients come to us when they’re stuck, and we help them find a trial. We have an amazing team who can help you find a diabetes trial. We list all trials, so no bias.”

From our community:

@lwahlstrom: “80% are under enrolled preventing important breakthroughs & all participants get min. standard-of-care treatment.”

11. What is the biggest myth about clinical trials?

AT: “I’d say the biggest myth is that diabetes trials are only open to the ‘elite’ and not accessible for all. We need to spread the word!”

SD: “Striking a healthy balance as to what clinical trials are and are not is key. Some cynics feel that patients equal lab animals. That’s untrue. Idealists may feel that every trial equals a therapy. That’s also untrue. Balancing science, expectations, and hope are what clinical trials are made of.”

From our community:

@davidcragg: “Biggest myth is that all trials are well designed & data always published -many never publish, making input less valuable… patients need to feel it’s not tokenism but a key part of the process they have influence in (from the start)”

@delphinecraig: “I think myths incl. no compensation, uneasy about drugs/clinics/clinicians, cost to participant.”

@JDRFQUEEN: “’Messing up’ results. You always have the right to withdraw if your management is suffering.”

Meet TrialReach Match

A powerful new way to connect patients and researchers, and a #diabetestrialchat to discuss the latest in diabetes research

Did you know that researchers are constantly working on new treatments to improve the health of people with diabetes? The problem is; if you’re living with diabetes, how do you get involved? How do you find these researchers?

Good news: they’re looking for you too! In the US alone, diabetes researchers are looking for a half million patients to take part in their trials. Unfortunately, many of these trials will never get off the ground because they can’t find enough patients to get involved.

Why does this matter? One word: HOPE – for you and for other patients. New treatments require research, so the promise of a brighter future for people with diabetes depends on patients and researchers working together.


This is where TrialReach comes in: we help researchers and patients connect so that potential new treatments can get to the people who need them, faster. As part of this mission, we’re pleased to introduce TrialReach Match™: which is transforming the way patients find and take part in clinical trials. 

We’ve started with diabetes, and we will be launching other therapeutic areas throughout the year. Check out the video below for a quick explanation. And, if you’re interested in finding a trial for you, try TrialReach Match™ today.

If you’d like to learn more about diabetes clinical trials, please join our Twitter chat at 3PM ET this afternoon. We’ll be joined by our friends at Healthline, JDRF, and DiabetesMine, and we will be discussing the latest in medical research, as well as how patients can get involved. You can take part by using #diabetestrialchat. For more information, click here.